Planet Labs
Planet Labs' revenue rose 25.9% to $308 million in fiscal 2026. Its operating margin was −30.9%, up from −47.5% a year earlier. Free cash flow was $58 million. The diluted share count rose 5.4%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
Planet Labs lost money in fiscal 2026: a net loss of $247 million.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Planet Labs yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
What Planet Labs says to expect
- Third quarter fiscal 2027: revenue and margin
For the third quarter of fiscal year 2027, ending October 31, 2026, Planet expects revenue to be in the range of approximately $101 million to $105 million. Non-GAAP gross margin is expected to be in the range of approximately 56% to 58%.
- Full fiscal year 2027: revenue and margin
For the full fiscal year 2027, Planet expects revenue to be in the range of approximately $430 million to $441 million. Non-GAAP gross margin is expected to be in the range of approximately 55% to 57%.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Planet Labs' 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Planet Labs' cash from operations minus depreciation in fiscal 2026 (free cash flow before spending to grow: capital spending was 1.8 times depreciation, which holds its free cash flow down) of $93M, net cash of $193M at January 31, 2026 and 308 million diluted shares, from its filings. The scenarios are fitted to Planet Labs: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 17.2% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 11%: 9% for a business of moderate risk (Aerospace & Defense), plus 1 point as a smaller company, worth $4.9B, plus 1 point for unsteady results (a loss in fiscal 2026); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $13.76
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
The P/E method needs positive earnings, and Planet Labs' latest diluted earnings per share were negative or zero.
Balance sheet
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | 491 | 409 | 299 | 222 | 640 |
| Debt incl. finance leases | 0 | 0 | 0 | 0 | 447 |
| Net debt (negative means net cash) | −491 | −409 | −299 | −222 | −193 |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | 0.0x | 0.0x | 0.0x | 0.0x | 2.4x |
| Interest coverage | −14.6x | — | — | −139.6x | −27.7x |
| Current ratio | 4.2x | 3.9x | 2.7x | 2.1x | 1.6x |
| Quick ratio | 4.2x | 3.9x | 2.7x | 2.1x | 1.6x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Planet Labs shares on the open market, and 8 insiders sold $43.0 million, $30.0 million of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Kristen RobinsonDirector | Sold plan | 40,000 | $14.14 | $565,560 | Form 4 |
| Oct 13, 2026 | John w RaymondDirector | Sold plan | 6,494 | $15.23 | $98,893 | Form 4 |
| Sep 17, 2026 | Ashley F. JohnsonPresident & CFO | Sold plan | 55,663 | $16.96 | $944,044 | Form 4 |
| Sep 17, 2026 | Robert H SchinglerCo-Founder Chief Strategy Off., Director | Sold plan | 52,240 | $16.96 | $885,990 | Form 4 |
| Jul 23, 2026 | Ashley F. JohnsonPresident & CFO | Sold plan | 110,028 | $22.08 | $2.4 million | Form 4 |
| Jul 15, 2026 | Kristen RobinsonDirector | Sold plan | 37,107 | $25.05 | $929,530 | Form 4 |
| Jul 13, 2026 | John w RaymondDirector | Sold plan | 6,494 | $26.16 | $169,883 | Form 4 |
| Jul 10, 2026 | William Spencer MarshallCo-Founder and CEO, Director | Sold plan | 200,000 | $25.92 | $5.2 million | Form 4 |
| Jul 10, 2026 | Robert H SchinglerCo-Founder Chief Strategy Off., Director | Sold plan | 89,593 | $25.92 | $2.3 million | Form 4 |
| Jul 1, 2026 | Ita M BrennanDirector | Sold plan | 11,500 | $33.00 | $379,500 | Form 4 |
| Apr 15, 2026 | Ita M BrennanDirector | Sold plan | 36,500 | $33.91 | $1.2 million | Form 4 |
| Apr 6, 2026 | William Spencer MarshallCo-Founder and CEO, Director | Sold plan | 200,000 | $35.07 | $7.0 million | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Fail | Fail | Pass |
| Return on assets rose | Pass | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Fail | Fail |
| Current ratio rose | Fail | Fail | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Pass | Fail |
| Revenue rose relative to assets | Pass | Pass | Pass |
| F-score | 4 of 9 | 4 of 9 | 3 of 9 |
| Accruals ratio | −12.3% | −16.3% | −42.9% |
Compare
Put Planet Labs side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Planet Labs | FY26 | 25.9% | −30.9% | 18.7% | −70.0% | — | 3 | |
| Intuitive Machines | FY25 | −7.9% | −41.5% | −26.6% | — | — | 3 | Compare |
| Kratos Defense & Security Solutions | FY25 | 18.5% | 1.9% | −10.2% | 1.2% | −6.3x | 4 | Compare |
| Joby Aviation | FY25 | 39,183.1% | −1,346.9% | −1,055.3% | — | — | — | Compare |
| Hexcel | FY25 | −0.5% | 9.1% | 8.3% | 6.5% | 3.1x | 6 | Compare |
7 years of figures
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 96 | 113 | 131 | 191 | 221 | 244 | 308 |
| Revenue growth | — | 18.2% | 15.9% | 45.8% | 15.4% | 10.7% | 25.9% |
| Gross profit | −7 | 26 | 48 | 94 | 113 | 140 | 172 |
| Research and development | 38 | 44 | 67 | 111 | 116 | 101 | 107 |
| Operating income | −106 | −87 | −128 | −176 | −170 | −116 | −95 |
| Net income | −124 | −127 | −137 | −162 | −140 | −123 | −247 |
| Diluted EPS (US$) | −2.89 | −2.87 | −1.72 | −0.61 | −0.50 | −0.42 | −0.80 |
| Diluted shares (millions) | 43 | 44 | 80 | 267 | 280 | 292 | 308 |
| Cash flow | |||||||
| Cash from operations | −34 | −4 | −42 | −74 | −51 | −14 | 134 |
| Capital expenditure | 17 | 26 | 10 | 10 | 38 | 44 | 77 |
| Free cash flow | −50 | −30 | −53 | −84 | −89 | −59 | 58 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 2 | 0 | 10 | 4 | 8 | 1 | 5 |
| Stock-based compensation | 5 | 14 | 42 | 76 | 57 | 48 | 55 |
| Balance sheet at fiscal year end | |||||||
| Cash and short-term investments | 28 | 71 | 491 | 409 | 299 | 222 | 640 |
| Debt incl. finance leases | — | 93 | 0 | 0 | 0 | 0 | 447 |
| Total assets | — | 399 | 821 | 753 | 702 | 634 | 1,146 |
| Total liabilities | — | 292 | 173 | 177 | 184 | 192 | 957 |
| Shareholders' equity | 218 | 108 | 648 | 576 | 518 | 441 | 188 |
| Margins and ratios | |||||||
| Gross margin | −7.0% | 22.8% | 36.8% | 49.1% | 51.2% | 57.2% | 56.0% |
| Operating margin | −111.2% | −77.3% | −97.6% | −91.8% | −76.9% | −47.5% | −30.9% |
| Net margin | −129.2% | −112.3% | −104.5% | −84.7% | −63.7% | −50.4% | −80.2% |
| Free cash flow margin | −52.6% | −26.6% | −40.0% | −44.1% | −40.2% | −24.0% | 18.7% |
| Return on capital | — | — | −70.5% | −85.5% | −69.4% | −41.9% | −70.0% |
| Return on equity | — | — | −36.3% | −26.5% | −25.7% | −25.7% | −78.4% |
| Return on assets | — | — | −22.5% | −20.6% | −19.3% | −18.4% | −27.8% |
| Net debt to EBITDA | — | — | — | — | — | — | — |